Defiance ETFs’s Johnson & Johnson JNJ Stock Holding History

Defiance ETFs’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.59M	Buy	10,189 +2,081	+26%	+$485K	0.04%	203
2026 Q1	$1.98M	Buy	+8,108	New	+$1.89M	0.03%	173

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Defiance ETFs's JNJ Position: Q2 2026 in Review

Defiance ETFs increased its Johnson & Johnson (JNJ) stake by 26% in Q2 2026, buying an estimated $485K and bringing the position to 10,189 shares worth $2.59M. The position accounts for 0.04% of the portfolio, ranked #203.

Defiance ETFs first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Defiance ETFs held 10,189 shares of Johnson & Johnson worth $2.59M as of Q2 2026.
Defiance ETFs bought 2,081 Johnson & Johnson shares in Q2 2026, an estimated $485K.
Johnson & Johnson made up 0.04% of Defiance ETFs's portfolio in Q2 2026, its #203 holding.
Defiance ETFs first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.